Clorox: Matthew J. Shattock acquires 648 stock units
The Deferred Stock Units will be settled 100% in Clorox stock upon Matthew J. Shattock’s retirement or other termination of service as a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clorox director Matthew J. Shattock acquired 648.0681 Deferred Stock Units on September 30, 2026, in lieu of quarterly director's fees, and 255.3782 units on August 28, 2026, through dividend reinvestment during the fiscal year under the Independent Directors' Deferred Compensation Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F4, F3 | 648.0681 | $0.00 | $0.00 |
| Grant/Award | Deferred Stock Units F1, F2, F3 | 255.3782 | $0.00 | $0.00 |
Footnotes (4)
- F1. 1-for-1
- F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
- F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
- F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
Key Figures
Key Terms
Deferred Stock Units financial
dividend reinvestment financial
Independent Directors' Deferred Compensation Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Deferred Stock Units did CLX director Matthew J. Shattock acquire?
AI-generated analysis. How Rhea-AI works. Not financial advice.